Loading Complete
Enid Neptune

Enid Neptune, MD

Pulmonology

Accepting New Patients

Highlights

Languages

  • Spanish
  • English

Gender

Female

Johns Hopkins Affiliations:

  • Johns Hopkins School of Medicine Faculty

About Enid Neptune

Primary Academic Title

Associate Professor of Medicine

Background

Dr. Neptune is a pulmonary, critical care physician with expertise in genetic disorders of the matrix with pulmonary manifestations. She is also skilled in the management of patients with advanced obstructive lung disease, especially emphysema. Dr. Neptune has extensive expertise in the diagnosis and management of the pulmonary complications of Marfan Syndrome, Loeys-Dietz Syndrome, vascular Ehlers Danlos Syndrome and other matrix disorders and serves on the Professional Advisory Board of the Marfan Foundation.  She is also an expert on tobacco dependence and is the Vice-Chair of the Tobacco Action Committee of the American Thoracic Society. 

Dr. Neptune earned her M.D. from Harvard Medical School. She completed her residency and performed a fellowship in pulmonary and critical care at the University of California, San Francisco. She also performed a fellowship in genetics at Johns Hopkins. 

Her research interests include therapeutic strategies in Marfan syndrome; mechanisms and prevention of progression of COPD; and hepatocyte growth factor signaling in airspace homeostasis. Dr. Neptune is committed to creating a diverse research community and clinical workforce. She is involved in multiple diversity initiatives at Johns Hopkins and the American Thoracic Society. She is also involved in increasing awareness of tobacco dependence and the needed regulatory policies.

Dr. Neptune serves on the Compliance Compensation Subcommittee for the Department of Medicine.

Recent News Articles and Media Coverage

Additional Academic Titles

Associate Professor of Genetic Medicine

Research Interests

Hepatocyte growth factor signaling in airspace homeostasis, Mechanisms and prevention of progression of COPD, Therapeutic strategies in Marfan syndrome

Lab Website

Enid Neptune Lab

  • Work in the Enid Neptune Lab focuses on topics within the fields of pulmonary and critical care medicine. Our research centers primarily on therapeutic strategies for Marfan syndrome and hepatocyte growth factor signaling in airspace homeostasis. We also conduct research on chronic obstructive pulmonary disease (COPD), with a focus on its mechanisms and potential methods for preventing its progression. Our research within critical care has most recently involved investigating superoxide dismutase 3 dysregulation in neonatal lung injuries.

Research Summary

Dr. Neptune has a research focus on regenerative approaches to COPD-emphysema, mucus hypersecretion in COPD, genetic disorders of the matrix and health disparities in tobacco dependence.  She has been funded by the NIH, Marfan Foundation, March of Dimes, Maryland Stem Cell Research Foundation.    Her active research efforts include a detailed assessment of airway mucus properties that associate with COPD progression, the dissection of the role of TGF-b and angiotensin signaling in lung maintenance and repair, the identification of novel approaches to lung regeneration and the determination of the role of sleep apnea in Marfan aortic disease.   Her lab uses a combination of mouse and human reagents, novel genetically targeted animal models and primary lung resident cell based approaches.  Her long term goal is to provide therapeutic reagents that can reverse established emphysema in patients with acquired, congenital or genetic disorders.   Dr. Neptune is a standing member of the LIRR Study Section in the NHLBI, a member of the Board of Scientific Advisors at the NIH Clinical Center and the Program Committee Chair of the Respiratory Cell and Molecular Biology Assembly in the American Thoracic Society.

Selected Publications

  • Calvi C, Podowski M, Lopez-Mercado A, Metzger S, Misono K, Malinina A, Dikeman D, Poonyagariyon H, Ynalvez L, Derakhshandeh R, Le A, Merchant M, Schwall R, Neptune ER. “Hepatocyte growth factor, a determinant of airspace homeostasis in the murine lung.” PLoS Genet. 2013;9(2):e1003228. doi: 10.1371/journal.pgen.1003228. Epub 2013 Feb 14.

  • Calvi CL, Podowski M, D'Alessio FR, Metzger SL, Misono K, Poonyagariyagorn H, Lopez-Mercado A, Ku T, Lauer T, Cheadle C, Talbot CC Jr, Jie C, McGrath-Morrow S, King LS, Walston J, Neptune ER. Critical transition in tissue homeostasis accompanies murine lung senescence. PLoS One. 2011;6(6):e20712. doi: 10.1371/journal.pone.0020712. Epub 2011 Jun 21. PMID: 21713037

  • Hansel NN, Paré PD, Rafaels N, Sin DD, Sandford A, Daley D, Vergara C, Huang L, Elliott WM, Pascoe CD, Arsenault BA, Postma DS, Boezen HM, Bossé Y, van den Berge M, Hiemstra PS, Cho MH, Litonjua AA, Sparrow D, Ober C, Wise RA, Connett J, Neptune ER, Beaty TH, Ruczinski I, Mathias RA, Barnes KC; Lung Health Study. “Genome-wide association study identification of novel loci associated with airway responsiveness in chronic obstructive pulmonary disease.” Am J Respir Cell Mol Biol. 2015 Aug;53(2):226-34. doi: 10.1165/rcmb.2014-0198OC.

  • Hansel NN, Ruczinski I, Rafaels N, Sin DD, Daley D, Malinina A, Huang L, Sandford A, Murray T, Kim Y, Vergara C, Heckbert SR, Psaty BM, Li G, Elliott WM, Aminuddin F, Dupuis J, O'Connor GT, Doheny K, Scott AF, Boezen HM, Postma DS, Smolonska J, Zanen P, Mohamed Hoesein FA, de Koning HJ, Crystal RG, Tanaka T, Ferrucci L, Silverman E, Wan E, Vestbo J, Lomas DA, Connett J, Wise RA, Neptune ER, Mathias RA, Paré PD, Beaty TH, Barnes KC. “Genome-wide study identifies two loci associated with lung function decline in mild to moderate COPD.” Hum Genet. 2013 Jan;132(1):79-90. doi: 10.1007/s00439-012-1219-6. Epub 2012 Sep 18.

  • Lambert AA, Kirk GD, Astemborski J, Neptune ER, Mehta SH, Wise RA, Drummond MB. “A cross sectional analysis of the role of the antimicrobial peptide cathelicidin in lung function impairment within the ALIVE cohort.” PLoS One. 2014 Apr 17;9(4):e95099. doi: 10.1371/journal.pone.0095099.

  • Poonyagariyagorn HK, Metzger S, Dikeman D, Mercado AL, Malinina A, Calvi C, McGrath-Morrow S, Neptune ER. “Superoxide dismutase 3 dysregulation in a murine model of neonatal lung injury.” Am J Respir Cell Mol Biol. 2014 Sep;51(3):380-90. doi: 10.1165/rcmb.2013-0043OC.

Professional Activities

Johns Hopkins Department of Medicine, Compliance Compensation Subcommittee

Locations

  1. Johns Hopkins Bayview Medical Center
    • 5501 Hopkins Bayview Circle, Allergy & Asthma Center, 2nd Floor, Baltimore, MD 21224

    Expertise

    Education

    University of California San Francisco School of Medicine

    Fellowship, Pulmonary and Critical Care Medicine, 1998

    University of California San Francisco School of Medicine

    Residency, Internal Medicine, 1991

    Harvard Medical School

    Medical Education, MD, 1988

    Board Certifications

    Pulmonary Disease

    American Board of Internal Medicine, 1996

    Insurance

    Johns Hopkins providers accept various commercial health insurance plans. However, they may not be included in all of an insurance company's plans or offerings. This may include Exchange, Medicaid, Medicare, and specific limited benefit plans. Exceptions to participation also exist based on your employer’s benefits package and the provider's location or specialty. Please contact your insurer directly to make sure your doctor is covered by your plan. For more details, please review our Insurance Information.
    Search plans
    • Aetna
    • CareFirst
    • Cigna
    • First Health
    • Geisinger Health Plan
    • HealthSmart/Accel
    • Humana
    • Johns Hopkins Health Plans
    • MultiPlan
    • Pennsylvania's Preferred Health Networks (PPHN)
    • Point Comfort Underwriters
    • Private Healthcare Systems (PHCS)
    • UnitedHealthcare
    • Veteran Affairs Community Care Network (Optum-VACCN)